Sawtooth Solutions, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Sawtooth Solutions, LLC

  • $3.64 Billion
  • Q4 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 04, 2020
SELL
$1.5 - $9.38 $112,753 - $705,085
-75,169 Closed
0 $0
Q2 2020

Aug 06, 2020
SELL
$4.79 - $8.39 $35,259 - $61,758
-7,361 Reduced 8.92%
75,169 $631,000
Q1 2020

May 15, 2020
SELL
$3.44 - $7.21 $35,982 - $75,416
-10,460 Reduced 11.25%
82,530 $432,000
Q4 2019

Feb 12, 2020
BUY
$4.29 - $5.64 $152,638 - $200,671
35,580 Added 61.98%
92,990 $508,000
Q3 2019

Nov 07, 2019
BUY
$4.87 - $7.08 $279,586 - $406,462
57,410 New
57,410 $280,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.12B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email